Malecare sent questions to Albert Siu, MD, Chairperson of the U.S. Preventive Services Task Force about plans to review their 2012 recommendation against the use of the PSA test for prostate cancer screening. We thought that this information would be important since the USPTF is currently soliciting public comments on the research design of their review [...]
My good friend and fellow advocate Mike Scott (Prostate Cancer Info Link) introduced me to a new web site produced by the University of Chicago called Cost of Care (www.CostofCare.org). The site is designed around the novel idea that the cost we must pay for our cancer care has become another negative side effect or [...]
Clinical trials are vital if we expect to continue to see improvements in the treatments and medications that are available. Unfortunately, there are some historical abuses in clinical trials so many people do approach them with a level of distrust. In contemporary times the clinical trial system has many safeguards that did not exist even [...]
Approximately 2 years ago Malecare and the New York State Prostate Coalition began asking questions about where the State of New York was hiding approximately $3,000,000 in funding for prostate cancer research. Each year New York State residents are asked to check off a little box on their state tax return donating an additional dollar [...]
I have been relatively quiet about the skyrocketing cost of drugs, but it has now become impossible to remain out of the fray. A Pharmaceutical company recently acquired a drug called Daraprim, the drug treats potentially fatal parasitic infections. After its acquisition the company raised the price of Daraprim by almost 5,0000%. When confronted with [...]